Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,853 JPY | +1.31% | +4.09% | 0.00% |
May. 06 | Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints | MT |
May. 06 | UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT | MT |
Business Summary
Number of employees: 6,257
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Distribution Retail
99.7
%
| 594,589 | 99.8 % | 651,167 | 99.7 % | +9.52% |
Others
0.2
%
| 478 | 0.1 % | 1,236 | 0.2 % | +158.58% |
Retail Artificial Intelligence
0.1
%
| 432 | 0.1 % | 708 | 0.1 % | +63.89% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 595,500 | 100.0 % | 653,112 | 100.0 % | +9.67% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 122,318,300 | 38,609,400 ( 31.56 %) | 0 | 31.56 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
TRIAL HOLDINGS INC. 0.31% | 370,900 | 0.31% | 7,082,499 $ |
Company contact information
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.15B | |
+16.44% | 339B | |
+11.82% | 73.83B | |
-7.08% | 68.53B | |
+0.75% | 30.21B | |
+25.66% | 24.26B | |
+8.95% | 14.14B | |
+14.98% | 10.13B | |
+20.37% | 9.31B | |
-4.25% | 6.73B |
- Stock Market
- Equities
- 141A Stock
- Company Trial Holdings Inc.